Adagene Inc. ADAG
- muzastotug — Colorectal Cancer Phase 2
- ADG126 — Hepatocellular Carcinoma Phase 1
- ADG116 Phase 1
CTLA-4 (2 companies · 4 programs)
Companies with an active program directed at CTLA-4.
BriaCell Therapeutics Corp. BCTX
- Soluble CD80 Preclinical